WELLINGTON ROAD SURGERY — All Prescriptions & Medications — Page 12
Practice Code: M82028 | NEWPORT, TF10 7HG
Showing results 551-600 of 757
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Specialist food replacer sweet biscuits (0913261) | 24 | 8,815 | £413 | +67.3% ▲ |
| Chlorhexidine gluconate | 24 | 11.4K | £86 | +9.3% ▲ |
| 24 | 45 | £337 | +287.0% ▲ | |
| 24 | 990 | £2.0K | +69.6% ▲ | |
| Omega-3-acid ethyl esters | 23 | 1,400 | £635 | +8.8% ▲ |
| Vibegron | 23 | 690 | £575 | +650.3% ▲ |
| Potassium citrate | 23 | 24.5K | £464 | +171.1% ▲ |
| 23 | 3,550 | £483 | +74.3% ▲ | |
| Colesevelam hydrochloride | 22 | 3,960 | £1.5K | -42.0% ▼ |
| Buspirone hydrochloride | 22 | 1,726 | £229 | -56.3% ▼ |
| Valproic acid | 22 | 1,890 | £492 | -74.7% ▼ |
| Rimegepant | 22 | 194 | £2.4K | +124.3% ▲ |
| Biphasic insulin lispro | 22 | 305 | £1.9K | -48.8% ▼ |
| Liothyronine sodium | 22 | 3,530 | £12.7K | +3.1% ▲ |
| Raloxifene hydrochloride | 22 | 607 | £87 | +49.0% ▲ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 22 | 23.8K | £361 | -4.0% ▼ |
| Menthol | 22 | 11.0K | £406 | -21.9% ▼ |
| 22 | 1,060 | £5.4K | +85.7% ▲ | |
| Telmisartan with diuretic | 21 | 784 | £396 | +85.8% ▲ |
| Betamethasone sodium phosphate | 21 | 840 | £127 | +70.8% ▲ |
| Norethisterone | 21 | 1,293 | £207 | -56.7% ▼ |
| Combined ethinylestradiol 35mcg | 21 | 1,428 | £63 | +68.5% ▲ |
| Tube feed additive 1 kcal/ml higher protein liquid (0914051) | 21 | 731 | £1.2K | +54.5% ▲ |
| Prednisolone sodium phosphate | 21 | 640 | £365 | +64.6% ▲ |
| Erythromycin | 21 | 1,650 | £647 | +54.7% ▲ |
| 21 | 900 | £90 | +76.2% ▲ | |
| Linaclotide | 20 | 616 | £785 | +9.5% ▲ |
| Amiodarone hydrochloride | 20 | 560 | £31 | -69.0% ▼ |
| Citalopram hydrochloride | 20 | 375 | £245 | +24.6% ▲ |
| Acamprosate calcium | 20 | 3,096 | £345 | -42.6% ▼ |
| Metformin hydrochloride/sitagliptin | 20 | 1,168 | £631 | -46.6% ▼ |
| Apraclonidine | 20 | 1,052 | £4.6K | +58.8% ▲ |
| Fludroxycortide | 20 | 35 | £810 | +89.7% ▲ |
| 20 | 1,500 | £5.2K | -46.8% ▼ | |
| 20 | 600 | £2.2K | +63.2% ▲ | |
| 20 | 2,400 | £4.2K | +90.3% ▲ | |
| Mebeverine hydrochloride compound preparations | 19 | 1,056 | £916 | +68.1% ▲ |
| Zinc oxide | 19 | 758 | £80 | -8.2% ▼ |
| Acrivastine | 19 | 1,638 | £472 | +54.2% ▲ |
| Nitrazepam | 19 | 980 | £52 | -63.4% ▼ |
| Frovatriptan | 19 | 204 | £517 | +34.4% ▲ |
| Denosumab | 19 | 19 | £3.1K | -30.2% ▼ |
| Sodium feredetate | 19 | 8,800 | £250 | -33.7% ▼ |
| Oral rehydration salts | 19 | 370 | £165 | -34.2% ▼ |
| Tube feed 1.5 kcal/ml peptide based (0914032) | 19 | 780.0K | £18.4K | +98.1% ▲ |
| Timolol and brimonidine | 19 | 95 | £249 | +35.4% ▲ |
| Fluocinolone acetonide | 19 | 610 | £87 | +74.5% ▲ |
| 19 | 432 | £925 | -43.7% ▼ | |
| 19 | 2,540 | £456 | +82.6% ▲ | |
| 19 | 400 | £904 | +106.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.